Pulmonary response to methylcyclopentadienyl manganese tricarbonyl treatment in rats: Injury and repair evaluation

Histology and Histopathology

Volumn 21, Issue 10-12, 2006, Pages 1181-1192

  Halatek, T ^a   Opalska, B ^a   Rydzynski, K ^a   Bernard, A ^b  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

BrdU; Clara cell protein; Hyaluronic acid; Lung; MMT

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; BROXURIDINE; CLARA CELL PROTEIN; COLLAGEN FIBER; DNA; ELASTIN; HYALURONIC ACID; METHYLCYCLOPENTADIENYLMANGANESE TRICARBONYL; 2 METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL; 2-METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL; CLARA CELL SPECIFIC PROTEIN; CLARA CELL-SPECIFIC PROTEIN; GLUTATHIONE TRANSFERASE; ORGANOMETALLIC COMPOUND; UTEROGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; BRONCHUS MUCOSA; CELL DAMAGE; CELL REGENERATION; CELL SWELLING; CELL VACUOLE; CLARA CELL; CONTROLLED STUDY; EPITHELIUM CELL; EXPERIMENTAL STUDY; FEMALE; FIBROBLAST; IMMUNOCYTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MITOSIS; MORPHOLOGY; NEUTROPHIL; NONHUMAN; RAT; SMOOTH ENDOPLASMIC RETICULUM; TISSUE REPAIR; ANIMAL; BRONCHUS; DRUG EFFECT; ENDOPLASMIC RETICULUM; EPITHELIUM; IMMUNOHISTOCHEMISTRY; INJURY; LUNG; LUNG ALVEOLUS; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; WISTAR RAT;

ANIMALIA;

ANIMALS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; ENDOPLASMIC RETICULUM; EPITHELIUM; FEMALE; GLUTATHIONE TRANSFERASE; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; LUNG; ORGANOMETALLIC COMPOUNDS; PULMONARY ALVEOLI; RATS; RATS, WISTAR; UTEROGLOBIN;

EID: 33750322314     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Aniya Y. and Naito A. (1993). Oxidative stress-induced activation of microsomal glutathione S-transferase in isolated rat liver. Biochem. Pharmacol. 45, 37-42.
2. Bernard A., Marchandise F.X., Depelchin S., Lauwerys R. and Sibille Y. (1992). Clara cell protein in serum and bronchoalveolar lavage. Eur. Resp. J. 5, 1231-1238.
3. Bjermer L., Engstrom-Laurent A., Lundgren R.., Rosenhall L. and Hallgren R. (1987). Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Br. Med. J. Clin. Res. 295, 803-806.
4. Blanchard K.T., Clay R.J. and Morris J.B. (1996). Pulmonary activation and toxicity of Cyclopentadienyl Manganese Tricarbonyl. Toxicol. Appl. Pharmacol. 136, 280-288.
5. Blaschke E., Eklund A. and Hernbrand R. (1990). Determination of fibronectin and its degradation products in bronchoalveolar lavage fluid. Scand. J. Clin. Lab. Invest. 50, 619-626.
6. Boutin A-C., Shirali P., Garcon G., Gosset P., Leleu B., Marez T., Bernard A. and Haguenoer J-M. (1998). Peripherial markers (Clara cell protein and α-glutathione S-transferase) and lipoperoxidation (malondialdehyde) assessment in Sprague-Dawley rats instilled with haematite and Benzo[a]pyrene. J. Appl. Toxicol. 18, 39-45.
7. Boyd M.R. and Reznik-Schuller H.M. (1984). Metabolic basis for the pulmonary Clara cell as a target for pulmonary carcinogenesis. Toxicol. Pathol. 12, 56-61.
8. Boyd M.R. (1977). Evidence for the Clara cell as a site of cytochrome P-450-dependent mixed-function oxidase activity in lung. Nature 269, 713-715.
9. Broeckaert F., Arsalane K., Hermans C., Bergamaschi E., Brustolin A., Muttii A. and Bernard A. (2000). Srum Clara cell protein: A sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ. Health Perspect. 108, 533-537.
10. Cantin A.M. and Begin R. (1991). Glutathione and inflamatory disorders of the lung. Lung 169, 123-138.
11. Clay R.J. and Morris J.B. (1989). Comparative pneumotoxicity of Cyclopentadienyl Manganese Tricarbonyl and Methylcyclopentadienyl Manganese Tricarbonyl. Toxicol, Appl. Pharmacol. 98, 434-443.
12. Cooper E.H. and Rathbone B.J. (1990). Clinical significance of the immunometric measurements of hyaluronic acid. Ann. Clin. Biochem. 27, 444-451.
13. Cox D.N., Traiger G.J., Jacober S.P. and Hanzlik R.P. (1987). Comparison of the toxicity of methylcyclopentadienyl manganese tricarbonyl with that of its two major metabolites. Toxicol. Lett. 39, 1-5.
14. Davidson J.M. (1990). Biochemistry and turnover of lung interstitium. Eur. Respir. J. 3, 1048-1068.
15. Dunsmore S.E., Lee Y.C., Martinez-Williams C. and Rannels E. (1996). Synthesis of fibronectin and laminin by type 11 pulmonary epithelial cells. Am. J. Physiol. 270. (Lung Cell. Mol. Physiol 14) L215-L223.
16. Durham S.K. and Gijbels M.J. (1989). Long-term morphologic and biochemical changes induced by O,O,S-Trimethyl Phosphorothiolate in rat lung. Toxicol. Appl. Pharmacol. 98, 465-474.
17. Engstrom-Laurent A., Laurent U.B.G., Lilij K. and Laurent T. (1985). Concentration of sodium hyaluronate in serum. Scand. J. Clin. Lab. Invest. 45, 497-504.
18. Evans M.J., Cabral-Anderson L.J. and Freeman G. (1978). Role of the Clara cell in the renewal of the terminal bronchiolar epithelium in the rat. Lab. Invest. 38, 648-655.
19. Forkert P.G. (1985). Bromobenzene causes Clara cell damage in mice. Can. J. Physiol. Pharmacol. 63,1480-1484.
20. Habig W., Pabst M. and Jakoby W. (1974). Glutatione S-transferase: the first enzymatic step in mercapturic acid formation. J. Biol. Chem, 249,130-7139.
21. Hackett B.P., Shimizu N. and Gitlin J.D. (1992). Clara cell secretory protein gene expression in bronchiolar epithelium. Am. J. Physiol. 262, L399-404.
22. Hakkinen R.P. and Haschek W.M. (1982). Pulmonary toxicity of methylcyclopentadienyl manganese tricarbonyl: nonciliated bronchiolar epithelial (Clara) cell necrosis and alveolar damage in the mouse, rat, and hamster. Toxicol. Appl. Pharmacol. 65,11-22.
23. Halatek T., Hermans C., Wattier R., Falamagne P., Toubeau G. and Bernard A. 1(1998). Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur. Resp. J. 11, 726-733.
24. Halatek T., Opalska B., Swiercz R., Palczynski C., Górski P., Rydzynski K. and Bernard A (2003). Glutaraldehyde inhalation exposure of rats: Effects on morphology of the lungs and Clara cell protein and hyaluronic acid levels in BAL. Inhal. Toxicol. 15, 85-97.
25. Hallgren R., Eklund A., Engstrom-Laurent A. and Schmekel B. (1985). Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br. Med. J. 290, 1778-1781.
26. Hanzlik R.P., Stitt R. and Traiger G.J. (1980). Toxic effects of Methylcyclopentadienyl Manganese Tricarbonyl (MMT) in rats: Role of metabolism. Toxicol. Appl. Pharmacol. 56, 353-360.
27. Harard A-L., Zahm J-M., Pierrot D., Hinnrasky J., Fuchey C. and Puchelle E. (1996). Epithelial barrier integrity during in vitro wound repair of the airway epithelium. Am. J. Respir. Cell. Mol. Biol. 5, 624-632.
28. Haschek W.M., Hakkinen P.J., Witschi H.P., Hanzlik R.P. and Traiger G.J. (1982). Nonciliated bronchiolar epithelial (Clara) cell necrosis induced by organometallic carbonyl compounds. Toxicol. Lett. 14, 85-92.
29. Haschek W. and Witschi H. (1979). Pulmonary fibrosis - a possible mechanism. Toxicol. Appl. Pharmacol. 51, 475-487.
30. Hinderer R.K. (1979). Toxicity studies of methylcyclopentadienyl manganese tricarbonyl (MMT). Amer. Ind. Hyg. Assoc. J. 40, 164-167.
31. Jones J.G., Royston, D. and Minty B.D. (1983). Changes in alveolar-capillary barrier function in animals and humans. Am. Rev. Respir. Dis. 127, S51-S59.
32. Jones K.G. Holland J.F., Foureman G.L., Bend J.R. and Fouts J.R. (1983). Xenobiotic metabolism in Clara cells and in alveolar type 11 cells isolated from rats treated with β-naphtaflavone. J. Pharmacol. Exp. Ther. 225, 316-319.
33. Jorens Ph.G., Sibille Y., Gouldin N.J., Van Overveld F.J., Herman A.G., Bossaert L., De Backer W.A., Lauwerys R., Flower R.J. and Bernard A. (1995). Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur. Resp. J. 8, 1647-1653.
34. Lesur C., Bernard A., Arsalane K., Lauwerys R., Bégin R., Cantin A. and Lane D. (1995). Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am. J. Resp. Crit. Care Med. 152, 290-297.
35. Lin C.Y., Isbell M.A., Morin D., Boland B.C., Salemi M.R., Jewell W.T., Weir A.J., Fanucchi M.V., Baker G.L., Plopper C.G. and Buckpitt A.R. (2005) Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomes. Chem. Res. Toxicol. 218, 802-813.
36. Mainwaring G.W., Williams S.M., Foster J.R., Tugwood J. and Green T. (1996). Distribution of Theta-class glutathione S-transferases in the liver and lung of mouse, rat and humans. Biochem. J. 318, 297-303.
37. Mantile C., Miele L., Cordella-Miele E., Singh G., Katyal S. and Mukherjee A.B. (1993). Human Clara cell 10 KDa protein is the counterpart of rabbit uteroglobin. J. Biol. Chem. 268, 20343-20351.
38. Meister A. and Anderson M.E. (1983). Glutathione. Ann. Rev. Biochem. 52, 711-760.
39. McGinley P.A., Morris J.B., Clay R.J. and Gianutsos G. (1987). Disposition and toxicity of methylcyclopentadienyl manganese tricarbonyl in the rat. Toxicol. Lett. 366, 137-145.
40. Miele L., Cordella-Miele E. and Mukherjee A.B. (1987). Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor. Endocrine Rev. 8, 474-490.
41. Monteil C., Le Prieur E., Buisson S., Morin J.P., Guerbet M. and Jouany J.M. (1999). Acrolein toxicity: comparative in vitro study with lung slices and pneumocytes type II cell line from rats. Toxicology 133, 129-138.
42. Nettelbladt O., Bergh J., Schenholm M., Tengblad A. and Hallgren R. (1989). Accumulation of hyaluronic acid in the alveolar-interstitial tissue in bleomycin-induced alveolitis. Am. Rev. Respir. Dis. 139, 759-762.
43. Penney D.A., Hogberg K., Traiger G.J. and Hanzlik R.P. (1985). The acute toxicity of cyclopentadienyl manganese tricarbonyl in the rat. Toxicology 34, 341-347.
44. Plopper C.G., Macklin J., Nishio S.J., Hyde D.M. and Buckpitt A.R. (1992). Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, rats after parenterall administration of naphthalene. Lab. Invest. 67, 553-565.
45. Rennard S.I. and Crystal R.D. (1982). Fibronectin in human bronchoalveolar lavage fluid. Elevation in patients with interstitial lung disease. J. Clin. Invest. 69, 113-122.
46. Sagara Y., Dargusch R., Chambers D., Davis J., Schubert D. and Maher P. (1998). Cellular mechanisms of resistance to chronic oxidative stress. Free Radic. Biol. Med. 24, 1375-1389.
47. Sannes P.L., Khosla J. and Cheng P-W. (1996). Sulfation of extracellular matrices modifies responses of alveolar type II cells to fibroblast growth factors. Am. J. Physiol 271 (Lung Cell. Mol. Physiol 15), L688-L697.
48. Shulda G.S, Shukla A., Potts R.J., Osier M., Hart B.A. and Chiu J.F. (2000). Cadmium-mediated oxidative stress in alveolar epithelial cells induces the expression of gamma-glutamylcysteine synthetase catalytic subunit and glutathione S-transferase alpha and pi isoforms: potential role of activator protein-1. Cell Biol. Toxicol. 16, 347-362.
49. Sulkowska. M., Sulkowski S. and Dzieciol J. (1996). Type II alveolar epithelial cells promote fibrosis during development of experimental lung emphysema. Folia Histochem. Cytobiol. 34, 27-28.
50. Tan K.H., Meyer D.J. and Ketterer B. (1984). Inhibition of microsomal lipid peroxidation by glutathione and glutathione transferases B and AA. Role of endogenous phospholipase A2. Biochem. J. 220, 243-252.
51. Teder P. and Heldin P. (1997). Mechanism of impaired local hyaluronan turnover in bleomycin-induced lung injury in rat. Am. J. Respir. Cell Mol. Biol. 17, 376-385.
52. Van Kuijk F.J.G.M, Sevanian A., Handelman G.J. and Dratz E.A. (1987). A new role for phospholipase A2: Protection of membranes from lipid peroxidation damage. Trends Biochem. 12, 31-34.
53. Van Winkle L.S., Buckpitt A.R., Nishio S.J., Isaac J.M. and Plopper G. (1995) Cellular response in naphthalene-induced Clara cell injury and bronchiolar epitheliall repair in mice. Am. J. Physiol 269 (Lung Cell. Mol. Physiol 13), L800-L818.
54. Van Winkle L.S., Johnson A.A. Nishio S.J., Isaac J.M., Brown C.D. and Plopper G. (1999). Early events in naphtalene-iduced acute Clara cell toxicity. Am. J. Respir. Cell Mol. Biol. 21, 44-53.
55. Verschoyle R.D., Wolf C.R. and Dinsdale D. (1993). CYP2B1 is responsible for the pulmonary bioactivation and toxicity of butylated hydroxytoluene, O,O,S-trimethylphosphothiotate and methyl-cyclopentadienyl manganese tricarbonyl. J. Pharmacol. Exp. Ther. 226, 958-963.
56. Woods L.W., Wilson D.W., Schiedt M.J. and Giri S.N. (1993). Structural and biochemical changes in lungs of 3-methylindole-treated rats. Am. J. Pathol. 142, 129-138.
57. Zayed J. (2001). Use of MMT in Canadian gasoline. Health and environmental issues. Am. J. Ind Med. 39, 426-433.
58. Zheng W., Kim H. and Zhao Q. (2000). Comparative toxicokinetics of manganese chloride and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague-Dowley rats. Toxicol. Sciences 54, 295-301.